Trending News
News
News
Novel Method Automates the Growth of Cerebral Organoids
The new system can increase reproducibility in cerebral organoid research and shows promise for lowering levels of cellular stress.
News
Cell Division Enzyme Identified as Possible Cancer Treatment Target
Researchers studying how cancer cells divide have revealed potential new viable therapeutic targets for cancer treatment.
News
Less-Invasive Treatments Developed for Head and Neck Cancers
A combined radiotherapy and immunotherapy treatment before surgery offers a less invasive treatment strategy for head and neck cancers that usually don't respond well to immunotherapy.
News
Vaccine Tablet Prevents UTIs in Mice
A vaccine tablet has been designed that dissolves when placed under the tongue, allowing mucus-penetrating nanofibers that contain E. coli proteins to enter the body and produce an immune response, preventing UTIs.
News
Existing Drugs Show Promise as Kidney Cancer Treatment
Researchers have discovered a potential drug target to treat renal cell carcinoma.
News
New Branch in Fungal Evolution Discovered
A new study by University of Alberta scientists has helped to classify ~600 fungi that, previously, lacked a place among the fungi family tree.
News
Nanoparticles Co-Deliver Chemotherapy and Immunotherapy To Shrink Tumors in Mice
Researchers have designed cancer-fighting nanoparticles that deliver both a chemotherapy drug and a novel immunotherapy that can shrink colon and pancreatic tumors in mice.
News
Synthetic DNA Can Control Cells’ Protein Production
Artificial intelligence has helped researchers to design synthetic DNA that can control cells' protein production, which could contibute to vaccine and drug development.
News
Is Ayahuasca Safe? Ask the Researcher
A recent study analyzed the adverse effects reported by users of the hallucinogenic tea, ayahuasca. In this Ask the Researcher, we spoke with the lead author of the study Dr. Daniel Perkins about the key findings and their implications for public health.
News
New Drug Candidate Developed for Epilepsy Treatment
Researchers have identified and developed a new drug candidate that has the potential for effectively treating temporal lobe epilepsy by suppressing neuroinflammation.
Advertisement